2015•China Modern MedicineRequires access

Clinical effect of quetiapine combined with sodium valproate in the treatment of bipolar disorder manic

Tan Rong-re

Open publisher page 0 citations

Abstract

Objective To observe the effectiveness and safety of quetiapine combined with sodium valproate in the treatment of bipolar disorder manic. Methods From March 2012 to March 2014,80 patients with bipolar disorder manic treated in our hospital were selected and randomly divided into the research group(n=40) and control group(n=40).The control group was given quetiapined,while the research group was given quetiapine combined with sodium valproate.The course of treatment lasted 8 weeks.The therapeutic effect was evaluated by Bech-Rafaelsen mania scale(BRMS).The total effective rate,the incidence rate of adverse reaction in the two groups were compared. Results After 4,8 weeks treatment,BRMS score of the research group was greatly lower than that in the control group with a statistical difference(P 0.05). After 8 weeks treatment,there was no statistical difference of the total effective rate in the two groups(P 0.05). There was a statistical difference of the incidence rate of adverse reaction in the two groups(P 0.05).Conclusion Quetiapine combined with sodium valproate in the treatment of bipolar disorder manic obtains a definite therapeutic effect.It is safe and reliable,and is worthy of clinical expansion and application.

About this research paper

What this paper is about

Objective To observe the effectiveness and safety of quetiapine combined with sodium valproate in the treatment of bipolar disorder manic. Methods From March 2012 to March 2014,80 patients with bipolar disorder manic treated in our hospital were selected and randomly divided into the research group(n=40) and control group(n=40).The control group was given quetiapined,while the research group was given quetiapine combined with sodium valproate.The course of treatment lasted 8 weeks.The therapeutic effect was evaluated by Bech-Rafaelsen mania scale(BRMS).The total effective rate,the incidence rate of adverse reaction in the two groups were compared. Results After 4,8 weeks treatment,BRMS score of the research group was greatly lower than that in the control group with a statistical difference(P 0.05). After 8 weeks treatment,there was no statistical difference of the total effective rate in the two groups(P 0.05). There was a statistical difference of the incidence rate of adverse reaction in the two groups(P 0.05).Conclusion Quetiapine combined with sodium valproate in the treatment of bipolar disorder manic obtains a definite therapeutic effect.It is safe and reliable,and is worthy of clinical expansion and application.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effectiveness and safety of quetiapine combined with sodium valproate in the treatment of bipolar disorder manic. Methods From March 2012 to March 2014,80 patients with bipolar disorder manic treated in our hospital were selected and randomly divided into the research group(n=40) and control group(n=40).The control group was given quetiapined,while the research group was given quetiapine combined with sodium valproate.The course of treatment lasted 8 weeks.The therapeutic effect was evaluated by Bech-Rafaelsen mania scale(BRMS).The total effective rate,the incidence rate of adverse reaction in the two groups were compared. Results After 4,8 weeks treatment,BRMS score of the research group was greatly lower than that in the control group with a statistical difference(P 0.05). After 8 weeks treatment,there was no statistical difference of the total effective rate in the two groups(P 0.05). There was a statistical difference of the incidence rate of adverse reaction in the two groups(P 0.05).Conclusion Quetiapine combined with sodium valproate in the treatment of bipolar disorder manic obtains a definite therapeutic effect.It is safe and reliable,and is worthy of clinical expansion and application.

Key concepts: Quetiapine, Medicine, Mania, Bipolar disorder, Incidence (geometry), Significant difference, Internal medicine, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical effect of quetiapine combined with sodium valproate in the treatment of bipolar disorder manic — Research Paper | ScholarLens